EUCRATES BIOMEDICAL ACQU COR's ticker is EUCR and the CUSIP is G3141W106. A total of 38 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $802,000 | -1.8% | 80,000 | -3.1% | 0.00% | -100.0% |
| Q2 2022 | $817,000 | -2.5% | 82,556 | -3.0% | 0.00% | – |
| Q1 2022 | $838,000 | -27.2% | 85,112 | -40.5% | 0.00% | -100.0% |
| Q4 2021 | $1,151,000 | -0.8% | 143,089 | -0.1% | 0.00% | 0.0% |
| Q3 2021 | $1,160,000 | +221.3% | 143,289 | +291.3% | 0.00% | – |
| Q2 2021 | $361,000 | – | 36,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SkyView Investment Advisors, LLC | 71,773 | $717 | 0.22% |
| EcoR1 Capital, LLC | 200,000 | $1,998,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,483 | $34,795 | 0.00% |
| Tower Research Capital LLC (TRC) | 657 | $7 | 0.00% |
| DEUTSCHE BANK AG\ | 21,923 | $219,011 | 0.00% |